Cactus that promises to curb the appetite
Tuesday 26 December 2006
Latest in Health News
On Facebook
Life & Style blogs
CC kills more people than cervical cancer; why haven’t we heard about it?
There is a disease whose incidence is rising in the UK and most of the industrialised world. However...
Time for a new approach to alcohol
Ambulances were called and three drunk teenagers were brought to my care. One was so drunk we had to...
London Fashion Week countdown
London Fashion Week is nearly upon us (again) and the invites are fast piling up. Our fashion team w...
A multi-million pound race between the world's biggest food companies is under way to tackle the global obesity epidemic by producing the first clinically-tested "satiety pill".
Three conglomerates - the Anglo-Dutch firm Unilever, France's Danone and Kraft in America - are researching compounds to achieve the hallowed goal of inducing people to eat less by suppressing their appetite.
With 300 million people worldwide rated as overweight or obese, the annual global cost of treatment and economic loss from the epidemic is now £100bn.
Scientists are increasingly placing their hopes in a range of natural substances which have the effect of duping the brain into "satiety" - the feeling of a full stomach. In the last 12 months, patents have been given appetite-suppressing extracts including Korean pine nuts and chicory roots. But at the head of the race to cash in on the £3bn worldwide market for dietary control products is Hoodia gordonii - a spiny cactus, which takes five years to mature in the Kalahari desert.
Hoodia contains a secret weapon - a compound known as P57 which has been isolated by a British bio-technology company, Phytopharm, and is now at the heart of a £21m research scheme funded by Unilever.
Phytopharm announced last month that it was making good progress in clinical trials of P57. The cucumber-like core of the Hoodia has been used for centuries by indigenous San tribesmen to stave off hunger pangs. They eat it on long hunting trips.
Unilever has struck a deal with the San to pay the tribe a royalty from the sales of any product containing P57 to be used in a social programme.
Phytopharm, which will also receive a royalty on sales of all products containing its Hoodia extract, warned last month that it was talking with authorities to curtail the sale of "Hoodia" products on the internet which claim to cause weight loss. Unilever is working to launch a range of "hunger buster" products based on Hoodia in 2009.
Phytopharm found that the compound closely mimics a natural substance in the body which sends a satiety message to the hypothalamus - the part of the brain that controls appetite.
Trials have shown that those taking P57 can cut their consumption by as much as 1,000 calories per day. The recommended calorie total for an adult man is 2,500 per day and for a woman, 2,000. A Unilever spokesman said: "We don't want to put our name to something that is not backed 100 per cent by the science behind it. We are now satisfied that the product works and has the potential to help with weight management."
The cash and energy being pumped into Unilever's project is mirrored by its rivals. Danone has patented new types of dietary fibre which slow the passage of food through the digestive system, making people feel full for longer. Kraft is working on a special form of starch which resists being broken down by the body, again designed to create the sense that the stomach is full.
But a senior executive with one conglomerate told The Independent: "Satiety has the potential to be one of the biggest earners of the next five years."
Many of the substances, including P57, work by affecting a mechanism in the ileum, part of the lower intestine, where the presence of fat triggers a response of satiety to the brain.
This "ileal brake" is triggered or mimicked by the compounds by disguising the fat molecules until they reach the ileum. In one case, the body is convinced it has consumed 500 calories when in reality it has had just 190.
However, according to Gary Frost, professor of nutrition and dietetics at Surrey University, humans have a "squirreling" instinct which encourages them to eat to excess in preparation for times of food scarcity. "There is a sense that for the company or companies that can isolate a proven appetite suppressant, there is a market waiting that would entail the vast majority of the population," he said. "It is a glittering prize but a controversial one - can you confidently say that one food will halt your desire for another?"
Neville Rigby, spokesman for the International Obesity Task Force, said: "The key to tackling obesity is eating decent food and balancing your calorie intake with the amount of energy you burn. There is no magic bullet."
- 1 Ninety gaffes in ninety years
- 2 Spotify: 1 million plays, £108 return
- 3 Apple admits it has a human rights problem
- 4 Rangers future could be bright says administrator
- 5 Rothschild loses libel case, and reveals secret world of money and politics
- 6 MP faces charges over Nazi stag night
- 7 Six Grammys, five years off: Adele puts love before career
- 8 No secularism please, we're British
- 9 Mark Steel: If religion is 'marginal', I'm the Pope
- 10 Lightning kills an entire football team
Free trial of new Independent iPad app
Get your daily dose of the best of British journalism, sponsored by American Airlines
Amazing restaurant offers
Three glasses of free champagne and a special menu at 46 top London restaurants.
Latest Independent competitions
Win anything from gadgets to five-star holidays on our competitions and offers page.
Commercial thought leaders
Watch the best in the business world give their insights into the world of business.
Career Services
Day In a Page
How an abortion divided America
Did they all live happily ever after? That's up to you...




Comments